No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device.

  1. Law
  2. South Carolina Code of Laws
  3. Health
  4. The Right To Try Act
  5. No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device.

Checkout our iOS App for a better way to browser and research.

If an eligible patient dies while being treated with an investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment.

HISTORY: 2016 Act No. 230 (H.4542), Section 2, eff June 3, 2016.


Download our app to see the most-to-date content.